Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003390326 | SCV004134614 | uncertain significance | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | SETD1B: PP2, BP4 |
Ambry Genetics | RCV004961301 | SCV005495642 | likely benign | Inborn genetic diseases | 2024-07-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |